Frazier Life Sciences Viii, L.P. is > 10% Shareholder of ALPINE IMMUNE SCIENCES, INC.. Currently has a direct ownership of 1.48 Million shares of ALPN, which is worth approximately $0. The most recent transaction as insider was on Feb 11, 2022, when has been sold 112,665 shares (Common Stock) at a price of $7.1 per share, resulting in proceeds of $799,921. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.48M
0% 3M change
0% 12M change
Total Value Held $0

Frazier Life Sciences VIII, L.P. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 11 2022
BUY
Open market or private purchase
$799,921 $7.1 p/Share
112,665 Added 7.06%
1,484,115 Common Stock
Sep 17 2021
SELL
Sale (or disposition) back to the issuer
-
1,200,000 Reduced 46.67%
1,371,450 Common Stock

Also insider at

ARQT
Arcutis Biotherapeutics, Inc. Healthcare
FLS

Frazier Life Sciences Viii, L.P.

> 10% Shareholder
Menlo Park, CA

Track Institutional and Insider Activities on ALPN

Follow ALPINE IMMUNE SCIENCES, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALPN shares.

Notify only if

Insider Trading

Get notified when an Alpine Immune Sciences, Inc. insider buys or sells ALPN shares.

Notify only if

News

Receive news related to ALPINE IMMUNE SCIENCES, INC.

Track Activities on ALPN